Medical Marijuana for Neurological Conditions in Florida

The Endocannabinoid System and the Brain

The human brain is densely populated with cannabinoid receptors — particularly CB1 receptors — making the nervous system one of the primary targets of cannabis-based therapy. The endocannabinoid system (ECS) plays a critical role in regulating neurotransmitter release, neuroinflammation, synaptic plasticity, and neuronal survival. When this system is disrupted — as it is in many neurological diseases — exogenous cannabinoids from medical cannabis can help restore balance.

Research into cannabis for neurological conditions has advanced significantly in recent years. The FDA's 2018 approval of Epidiolex (pharmaceutical-grade CBD) for treatment-resistant epilepsy marked a landmark moment — the first time a cannabis-derived drug received federal approval. This validated what neurologists and patients had observed for years: cannabinoids have genuine, clinically significant effects on neurological function.

Beyond epilepsy, a growing body of evidence supports the use of cannabis for spasticity in multiple sclerosis, tremor and rigidity in Parkinson's disease, agitation in Alzheimer's disease, and symptom management in ALS. The National Academies of Sciences, Engineering, and Medicine (2017) concluded that there is "conclusive or substantial evidence" that cannabis is effective for spasticity associated with multiple sclerosis, and "moderate evidence" supporting its use for sleep disturbances associated with several neurological conditions.

How Cannabinoids Protect and Support Neurons

The neuroprotective properties of cannabinoids operate through several mechanisms that are particularly relevant to neurological disease:

• Anti-inflammatory action — Both THC and CBD reduce neuroinflammation by modulating microglial cell activity and suppressing pro-inflammatory cytokine release. Chronic neuroinflammation is a driver of disease progression in MS, Alzheimer's, Parkinson's, and ALS.
• Antioxidant protection — CBD is a potent antioxidant that protects neurons from oxidative stress — a major contributor to neurodegeneration. The U.S. government holds a patent (US6630507B1) on cannabinoids as antioxidants and neuroprotectants, filed in 2003.
• Excitotoxicity reduction — CBD modulates glutamate signaling, reducing excitotoxicity — a process where excessive glutamate release damages neurons. This mechanism is particularly relevant in epilepsy, ALS, and stroke recovery.
• Neurogenesis support — Emerging research suggests that certain cannabinoids may promote the growth of new neurons in the hippocampus, which could have implications for Alzheimer's disease and traumatic brain injury recovery.

It is important to note that while these mechanisms are well-documented in preclinical research, their translation to clinical disease modification in humans is still under investigation. Current medical use of cannabis for neurological conditions focuses primarily on symptom management — reducing seizures, spasticity, pain, tremor, and sleep disturbances — rather than slowing disease progression.

Neurological Conditions That Qualify in Florida

All of the following neurological conditions qualify for medical marijuana certification in Florida under Statute 381.986:

Key Research: Cannabis and Neurological Disease

The evidence supporting cannabis for neurological conditions comes from a range of clinical and preclinical studies:

Recommended Products and Delivery Methods

Neurological conditions often require precise, consistent dosing — making certain delivery methods more suitable than others:

• CBD-dominant tinctures — First-line recommendation for most neurological conditions. Sublingual administration provides predictable absorption and allows precise dose titration. Onset in 15–30 minutes, duration 3–4 hours.
• Capsules — Ideal for patients who need consistent daily dosing and prefer a familiar medication format. Particularly useful for seizure management where dosing consistency is critical. Onset in 30–90 minutes, duration 4–8 hours.
• Vaporizers — Useful for acute symptom management (sudden spasticity, pain flares, tremor episodes). Fastest onset (1–5 minutes) but shortest duration (1–3 hours). Not recommended for patients with respiratory conditions.
• RSO (Rick Simpson Oil) — High-potency, full-spectrum extract used by some patients with severe neurological conditions. Requires careful dosing — Dr. Stratt provides specific guidance for RSO use. See our RSO guide.

Dr. Stratt develops individualized treatment plans for neurological patients that account for your specific condition, symptom profile, current medications, and daily functional needs. The complete guide to delivery methods provides additional detail on each option.

Important Considerations for Neurological Patients

If you are considering medical marijuana for a neurological condition, keep these factors in mind:

• Drug interactions — Cannabis can interact with anti-epileptic drugs (AEDs), levodopa, muscle relaxants, and benzodiazepines. Always disclose your complete medication list during evaluation. Dr. Stratt monitors for interactions and adjusts recommendations accordingly.
• Start low, go slow — Neurological patients are often more sensitive to psychoactive effects. Begin with low-dose, CBD-dominant products and titrate gradually. This approach minimizes side effects while finding your effective dose.
• Caregiver considerations — Many neurological patients benefit from having a designated caregiver who can assist with dispensary purchases and medication administration, particularly patients with advanced Parkinson's, Alzheimer's, or ALS.
• Coordination with your neurologist — Medical marijuana should complement, not replace, your existing neurological care. Dr. Stratt can communicate with your neurologist to ensure your cannabis treatment plan is integrated with your overall care.

Getting Certified: What to Bring

To evaluate you for medical marijuana certification, Dr. Stratt will need:

• A valid Florida ID or driver's license
• Medical records documenting your neurological diagnosis — neurologist reports, MRI/EEG results, or hospital discharge summaries
• Current medication list including dosages
• Any prior cannabis use history and its effects

For the complete step-by-step certification process, see our Florida Medical Marijuana Guide or How It Works page.

Further Reading: Neurological Conditions Guides

Dive deeper into specific neurological topics:

Frequently Asked Questions